Life Science Tools Market Summary
The global life science tools market size was estimated at USD 167.82 billion in 2024 and is projected to reach USD 401.01 billion by 2033, growing at a CAGR of 10.21% from 2025 to 2033. The main drivers of this growth are the expanding use of genomic technologies, increasing investments in pharmaceutical and biotechnology R&D, and the growing demand for sophisticated research instruments.
Global Life Science Tools Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the life science tools market report based on product & service, technology, end use, and region.
- Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
- Cell Culture Systems & 3D Cell Culture
- Instruments
- Consumables
- Cell & Tissue Culture Services
- Liquid Chromatography
- Instruments
- Consumables
- Services
- Mass Spectrometry
- Instruments
- Consumables
- Services
- Flow Cytometry
- Instruments
- Consumables
- Services
- Cloning & Genome Engineering
- Kits, Reagents, and Consumables
- Services
- Microscopy & Electron Microscopy
- Instruments
- Consumables
- Services
- Next Generation Sequencing
- Instruments
- Consumables
- Services
- PCR & qPCR
- Instruments
- Consumables
- Services
- Nucleic Acid Preparation
- Instruments
- Consumables
- Services
- Nucleic Acid Microarray
- Instruments
- Consumables
- Services
- Sanger Sequencing
- Instruments
- Consumables
- Services
- Transfection Devices & Gene Delivery Technologies
- NMR
- Instruments
- Consumables
- Services
- Other Separation Technologies
- Instruments
- Consumables
- Services
- Other Products & Services
- Antibodies
- General Supplies
- Others
- Instruments
- Consumables
- Services
- Technology Outlook (Revenue, USD Million, 2021 - 2033)
- Genomic Technology
- Proteomics Technology
- Cell Biology Technology
- Other Analytical & Sample Preparation Technology
- Lab Supplies & Technologies
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Government & Academic
- Biopharmaceutical Company
- Healthcare
- Industrial Applications
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Switzerland
- Asia Pacific
- Japan
- China
- India
- South Korea
- Singapore
- Australia
- Thailand
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait